CompletedPhase 2NCT01187901
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Studying Rare genetic tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Utah
- Principal Investigator
- Randall Burt, MDUniversity of Utah at Huntsman Cancer Institute
- Intervention
- Erlotinib(drug)
- Enrollment
- 92 enrolled
- Eligibility
- 18-69 years · All sexes
- Timeline
- 2010 – 2014
Study locations (1)
- Huntsman Cancer Institute, Salt Lake City, Utah, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01187901 on ClinicalTrials.govOther trials for Rare genetic tumor
Additional recruiting or active studies for the same condition.